Mergers & Acquisitions

Since 2009, Cooley has handled more than 750 mergers and acquisitions (M&A) transactions, with an aggregate value of over $140 billion, making our practice one of the most active in the world.

We represent all categories of participants in transactions, including buyers, sellers, major stockholders, lenders, financial advisors, management, special board committees, venture capitalists, individual investors, private equity funds, hedge funds and others. 

In addition to handling acquisitions of venture capital-backed corporations and other closely held entities, we regularly negotiate acquisitions involving large, publicly traded companies. 

Our experience and client base of over 145 publicly held companies provides us with a current perspective on market deal points, and a unique position from which we can draw to introduce buyers and sellers.

Cooley has highly skilled transactional lawyers who focus on M&A matters. These lawyers are widely recognized as leaders and experts in their field and are frequently invited to speak on M&A trends and take leadership roles in national professional organizations.

Cooley's M&A lawyers have been honored in numerous publications that list and rank the top lawyers in the United States and the world. Accolades have come from publications such as:

  • The Best Lawyers in America
  • Chambers Global Guide to the World's Leading Lawyers
  • Euromoney's Guide to the World's Leading Mergers and Acquisitions Lawyers
  • Legal 500
  • M&A Advisor – Law Firm of the Year (2004)

Recent Deals  (includes pending transactions)

 Adaptive acuisition of Sequenta  Auspex Pharmaceuticals acquired by Teva Pharmaceutical  Bounty Labs acquired by Twitter  Battery Ventures sale of Industrial Safety Technologies to Tyco International  Clearlake Capital acquisition of FrontRange  Curbstand acquisition of Curby  Datalogix acquired by Oracle  GlobalGrind acquired by Interactive One  Gray acquisition of Neuhoff Corp.'s KMVT-TV and KSVT-TV  Horizon Pharma acquisition of Hyperion Therapeutics  IGas Energy sale of shares to INEOS  Kite Pharma acquisition of T-Cell Factory B.V.  PrimeSport acquired by the Carlyle Group  Regado Biosciences merger with Tobira Therapeutics  Suppremol acquired by Baxter

View our extended deal list


"According to industry peers, the licensing, tax and inversion, private investment, capital market and M&A work performed by Cooley is top tier."

LMG Life Sciences

  • #6 US West by deal count (2014 Mergermarket Global and Region M&A)
  • #12 US by deal count (2014 Mergermarket Global and Region M&A)
  • #12 (tied) US Target Announced - Based on Number of Deals (2014 Thomson Reuters Global M&A Legal Advisory Review)
  • #17 US Announced Deals (2014 Bloomberg M&A Legal Advisory Rankings)
  • #12 US Announced Deals up to $500M (2014 Bloomberg M&A Legal Advisory Rankings)

Cross-border Experience

We have handled cross-border deals across 25 different jurisdictions, including:

  • Australia
  • Belgium
  • Canada
  • China
  • Denmark
  • Finland
  • India
  • Ireland
  • Israel
  • France
  • Germany
  • Japan
  • Korea
  • Netherlands
  • Norway
  • Poland
  • Romania
  • Singapore
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Related Practices

Cooley M&A Team News

Stay informed on recent judicial developments, practice pointers, publications and transactions from the M&A team.

April 2015
January 2015
September 2014
June 2014
March 2014
January 2014
December 2013
October 2013

©2003-2015 Cooley LLP and Cooley (UK) LLP. All rights reserved.
COOLEY® and the COOLEY LLP® logo are registered U.S. service marks of Cooley LLP.
Cooley was founded in 1920 – for our story, visit our timeline.